Telomerase activity in head and neck cancer

Anticancer Research

Volumn 28, Issue 5 B, 2008, Pages 3125-3129

  Kunická, Zuzana ^a,b   Mucha, Igor ^c   Fajkus, Jiří ^a,b  

^a MASARYK UNIVERSITY   (Czech Republic)

^b INSTITUTE OF BIOPHYSICS   (Czech Republic)

^c ST ANNE S UNIVERSITY HOSPITAL   (Czech Republic)

Author keywords

Head and neck cancer; Marker; Prognosis; Real time TRAP; Telomerase activity

Indexed keywords

TELOMERASE;

ADULT; AGED; ARTICLE; CANCER GRADING; CANCER GROWTH; CONTROLLED STUDY; ENZYME ACTIVITY; FEMALE; HEAD AND NECK CANCER; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; TELOMERIC REPEAT AMPLIFICATION PROTOCOL; TUMOR DIFFERENTIATION;

AGED; FEMALE; HEAD AND NECK NEOPLASMS; HUMANS; MALE; MIDDLE AGED; PROGNOSIS; SMOKING; TELOMERASE; TELOMERE; TUMOR MARKERS, BIOLOGICAL;

EID: 55749107116     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. Fajkus J, Simickova M and Malaska J: Tiptoeing to chromosome tips: facts, promises and perils of today's human telomere biology. Philos Trans R Soc Lond B Biol Sci 357: 545-562, 2002.
2. Bachor C, Bachor OA and Boukamp P: Telomerase is active in normal gastrointestinal mucosa and not up-regulated in precancerous lesions. J Cancer Res Clin Oncol 125: 453-460, 1999.
3. Counter CM, Avilion AA, LeFeuvre CE, Stewart NG, Greider CW, Harley CB and Bacchetti S: Telomere shortening associated with chromosome instability is arrested in immortal cells which express telomerase activity. EMBO J 11: 1921-1929, 1992.
4. Kim NW, Piatyszek MA, Prowse KR, Harley CB, West MD, Ho PL, Coviello GM, Wright WE, Weinrich SL and Shay JW: Specific association of human telomerase activity with immortal cells and cancer. Science 266: 2011-2015, 1994.
5. Granger MP, Wright WE and Shay JW: Telomerase in cancer and aging. Crit Rev Oncol Hematol 41: 29-40, 2002.
6. McCaul JA, Gordon KE, Clark LJ and Parkinson EK: Telomerase inhibition and the future management of head-and-neck cancer. Lancet Oncol 3: 280-288, 2002.
7. Landis SH, Murray T, Bolden S and Wingo PA: Cancer statistics, 1999. CA Cancer J Clin 49: 8-31, 1999.
8. Patel MM, Patel DD, Parekh LJ, Raval GN, Rawal RM, Bhatavdekar JM, Patel BP and Patel PS: Evaluation of telomerase activation in head and neck cancer. Oral Oncology 35: 510-515, 1999.
9. van den Heever WMJ, Pretorius GHJ and Smit SJA: Telomerase activity and survival of late-stage South African esophageal carcinoma patients. Dis Esophagus 17: 251-256, 2004.
10. Scully C, Field JK and Tanzawa H: Genetic aberrations in oral or head and neck squamous cell carcinoma (SCCHN): 1. Carcinogen metabolism, DNA repair and cell cycle control. Oral Oncol 36: 256-263, 2000.
11. Scully C, Field JK and Tanzawa H: Genetic aberrations in oral or head and neck squamous cell carcinoma 2: chromosomal aberrations. Oral Oncol 36: 311-327, 2000.
12. Jefferies S and Foulkes WD: Genetic mechanisms in squamous cell carcinoma of the head and neck. Oral Oncol 37: 115-126, 2001.
13. Patel MM, Parekh LJ, Jha FP, Sainger RN, Patel JB, Patel DD, Shah PM and Patel PS: Clinical usefulness of telomerase activation and telomere length in head and neck cancer. Head Neck 24: 1060-1067, 2002.
14. Liao CT, Chang JTC, Wang HM, Chen IH, Lin CY, Chen TM, Hsieh LL and Cheng AJ: Telomerase as an independent prognostic factor in head and neck squamous cell carcinoma. Head Neck 26: 504-512, 2004.
15. Koscielny S, von Eggeling F, Dahse R and Fiedler W: The influence of reactivation of the telomerase in tumour tissue on the prognosis of squamous cell carcinomas in the head and neck. Oral Pathol Med 33: 538-542, 2004.
16. Fajkus J, Koppova K and Kunicka Z: Dual-color real-time telomeric repeat amplification protocol. Biotechniques 35: 912-914, 2003.
17. Fajkus J: Detection of telomerase activity by the TRAP assay and its variants and alternatives. Clin Chim Acta 371: 25-31, 2006.
18. Bryan TM, Englezou A, Gupta J, Bacchetti S and Reddel RR: Telomere elongation in immortal human cells without detectable telomerase activity. Embo J 14: 4240-4248, 1995.
19. Malaska J, Sklenickova M, Krejci K, Fajkusova L, Bajer M, Hrstkova H and Fajkus J: Telomerase activity and expression and telomere analysis in situ in the course of treatment of childhood leukemias. Blood Cells Mol Dis 26: 534-539, 2000.
20. Shay JW and Bacchetti S: A survey of telomerase activity in human cancer. Eur J Cancer 33: 787-791, 1997.
21. Lee BJ, Wang SG, Choi JS, Lee JC, Goh EK and Kim MG: The prognostic value of telomerase expression in peripheral blood mononuclear cells of head and neck cancer patients. Am J Clin Oncol 29: 163-167, 2006.
22. Malaska J, Kunicka Z, Borsky M, Sklenickova M, Novotna M, Fajkusova L, Zaloudik J and Fajkus J: Telomerase as a diagnostic and predictive marker in colorectal carcinoma. Neoplasma 51: 90-96, 2004.